诚邀合作！第二届全球眼科大会

Core Viewpoint - The Second Global Ophthalmology Conference 2026 will be held on June 11, 2026, in Beijing, focusing on the integration of medicine and engineering, technological innovation, and clinical value in the ophthalmology industry [1]. Event Overview - The conference will cover various fields including ophthalmic imaging, refractive and myopia treatment, innovative therapies, surgical techniques, and preclinical validation [1]. - The event will also open applications for the "2026 Global Ophthalmology Annual Awards" and invite teams to co-author the "Global Ophthalmology Innovation White Paper" [2]. Conference Highlights - The conference will feature the release of the "2026 Global Ophthalmology Innovation White Paper" and the awarding of the "Ophthalmology Innovation Series Awards" to establish industry benchmarks [7]. - There will be premium exhibition spaces for sponsors to engage with high-quality decision-makers, product demonstrations, and collaboration opportunities [7]. - An "Innovation Demo Hour" will allow selected innovative teams to present their projects in 5-10 minute high-density pitches, addressing investment and collaboration needs [14]. Thematic Focus Areas - Next-Generation Ophthalmic Imaging and AI: This section will explore the integration of imaging and algorithms, focusing on academic advancements and practical applications [11]. - Refractive and Myopia: This segment will address the largest commercial segment in China's ophthalmology industry, discussing refined surgical developments and comprehensive strategies for myopia prevention [13]. - Surgical Innovations: This part will showcase the next-generation technologies in ophthalmic surgery, including robotics and real-time imaging [13]. - Device Development and Preclinical Validation: This section will present the system of "industrial service chains" to assist R&D and innovation companies in resource matching [13]. Participant Demographics - The conference will attract a diverse audience, including academic teams with recent research outcomes, engineering teams with prototype products, and early-stage innovative companies [16].